{"href":"http://player.captivate.fm/services/oembed?url=http%3A%2F%2Fplayer.captivate.fm%2Fepisode%2Fc31f3557-e4e9-4ca6-9eca-23b905d086ec","version":"1.0","provider_name":"Captivate.FM","provider_url":"https://www.captivate.fm","width":600,"height":200,"type":"rich","html":"<iframe style=\"width: 100%; height: 200px;\" title=\"Inside the Issue: Integrating HER2-Targeted Strategies into the Management of Gastrointestinal Cancers\" frameborder=\"0\" scrolling=\"no\" allow=\"clipboard-write\" seamless src=\"http://player.captivate.fm/episode/c31f3557-e4e9-4ca6-9eca-23b905d086ec\"></iframe>","title":"Inside the Issue: Integrating HER2-Targeted Strategies into the Management of Gastrointestinal Cancers","description":"\n        <p>Dr Tanios Bekaii-Saab from the Mayo Clinic Cancer Center in Phoenix, Arizona, and Dr John Strickler from Duke University in Durham, North Carolina, review clinical data supporting the application of HER2-targeted therapies for patients with gastrointestinal cancers, moderated by Dr Neil Love. Produced by Research To Practice. </p>\n\n<p>CME information and select publications <a href=\"https://www.researchtopractice.com/InsideTheIssue2024/HER2GI\" rel=\"nofollow\">here</a>. </p>\n      ","thumbnail_width":300,"thumbnail_height":300,"thumbnail_url":"https://artwork.captivate.fm/80132402-b9b0-4023-87ef-84d772bfc551/cover.jpg"}